Literature DB >> 9620328

Prognosis of hepatocellular carcinoma with diabetes mellitus after hepatic resection.

Y Ikeda1, M Shimada, H Hasegawa, T Gion, K Kajiyama, K Shirabe, K Yanaga, K Takenaka, K Sugimachi.   

Abstract

We evaluated the effect of diabetes mellitus on the prognosis of hepatocellular carcinoma after an elective hepatic resection. Of the 342 patients who underwent a hepatic resection between April 1985 and March 1995, 87 (25.4%) were diabetic. Postoperative morbidity was more common among diabetics than among nondiabetics (36.0% vs. 22.5%, P = .0239). The postoperative survival rate and the cancer-free survival rate were also better in patients without diabetes than in those with diabetes (P = .0333, P = .0149). The results of a multivariate analysis show diabetes mellitus to be an independent and prognostic indicator after a hepatic resection with hepatocellular carcinoma. According to the above findings, diabetes mellitus is thus considered to be a risk factor for prognosis after hepatic resection in patients with hepatocellular carcinoma.

Entities:  

Mesh:

Year:  1998        PMID: 9620328     DOI: 10.1002/hep.510270615

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  34 in total

Review 1.  Hepatocellular carcinoma--cause, treatment and metastasis.

Authors:  Z Y Tang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Diabetes mellitus is associated with increased mortality in patients receiving curative therapy for hepatocellular carcinoma.

Authors:  Wen-Yi Shau; Yu-Yun Shao; Yi-Chun Yeh; Zhong-Zhe Lin; Raymond Kuo; Chih-Hung Hsu; Chiun Hsu; Ann-Lii Cheng; Mei-Shu Lai
Journal:  Oncologist       Date:  2012-05-23

3.  Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer.

Authors:  Sarah A Little; William R Jarnagin; Ronald P DeMatteo; Leslie H Blumgart; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2002 Jan-Feb       Impact factor: 3.452

4.  Selection criteria for hepatectomy in patients with hepatocellular carcinoma classified as Child-Pugh class B.

Authors:  Shintaro Kuroda; Hirotaka Tashiro; Tsuyoshi Kobayashi; Akihiko Oshita; Hironobu Amano; Hideki Ohdan
Journal:  World J Surg       Date:  2011-04       Impact factor: 3.352

5.  Multivariate association analysis with somatic mutation data.

Authors:  Qianchuan He; Yang Liu; Ulrike Peters; Li Hsu
Journal:  Biometrics       Date:  2017-07-19       Impact factor: 2.571

6.  Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus.

Authors:  Hui Zhang; Chun Gao; Long Fang; Shu-Kun Yao
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

Review 7.  Diabetes mellitus and metformin in hepatocellular carcinoma.

Authors:  Koji Fujita; Hisakazu Iwama; Hisaaki Miyoshi; Joji Tani; Kyoko Oura; Tomoko Tadokoro; Teppei Sakamoto; Takako Nomura; Asahiro Morishita; Hirohito Yoneyama; Tsutomu Masaki
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

8.  Is diabetes mellitus a poor prognostic factor for hepatocellular carcinoma?

Authors:  Muhammed Adnan Masood; Waleed Zafar; Muhammed Aasim Yusuf
Journal:  J Gastrointest Cancer       Date:  2014-12

9.  Concurrent hyperglycemia does not influence the long-term prognosis of unresectable hepatocellular carcinomas.

Authors:  Xiao-Ping Li; Zhen Chen; Zhi-Qiang Meng; Wen-Xia Huang; Lu-Ming Liu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 10.  Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis.

Authors:  Bethany B Barone; Hsin-Chieh Yeh; Claire F Snyder; Kimberly S Peairs; Kelly B Stein; Rachel L Derr; Antonio C Wolff; Frederick L Brancati
Journal:  JAMA       Date:  2008-12-17       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.